Skip to main content

Samantha P. Kingsbury

Of Counsel

[email protected]

+1.617.348.1829

Follow:
Share:

Samantha’s practice focuses on defending clients in government investigations and advising on a wide array of fraud and abuse and compliance matters. She represents health care companies and providers in investigations and enforcement actions conducted by various federal and state enforcement agencies, including the US Department of Justice and/or its US Attorneys’ Offices, as well as state Offices of the Attorney General, among many others. Many such actions are initiated by qui tam complaints filed under the federal False Claims Act and allege violations of the federal Anti-Kickback Statute and Stark Law, among other authorities. Samantha has also represented clients in investigations involving consumer protection issues and COVID-related programs. She also negotiates and coordinates settlements with state and federal agencies, as well as corporate integrity agreements with the Office of Inspector General for the Department of Health and Human Services. 

In addition, Samantha advises clients on a wide variety of health care regulatory issues, including coverage, billing, and reimbursement, and arrangements with referral sources. She develops and implements compliance programs, structures and conducts internal investigations, advises on voluntary self-disclosure to government agencies, and defends administrative proceedings involving licensure and reimbursement issues, among other matters. 

Samantha is actively involved in pro bono matters at Mintz and previously served on the firm’s Pro Bono Committee. She manages the firm’s participation in the Lawyers Clearinghouse Legal Clinic for the Homeless, through which Mintz attorneys provide legal representation to residents of Boston-area homeless shelters. She also represents a wide variety of clients seeking pro bono services.  

Experience

  • Defended a diagnostics company in a national criminal and civil investigation involving multiple US Attorneys’ Offices and state Attorneys' General Offices. The investigation involved alleged kickback issues and billing violations with respect to the Medicare, Medicaid, and TRICARE programs, among other federal health care programs.
  • Represented a clinical laboratory in a False Claims Act investigation involving alleged violations of the Stark Law stemming from arrangements with referring physicians.
  • Defended a provider in an investigation conducted by the Federal Trade Commission involving alleged consumer protection violations.
  • Represented a health care company in a False Claims Act investigations involving alleged performance of, and billing of federal health care programs for, medically unnecessary services.
  • Advised several hospitals on submissions of self-disclosures under the CMS Self-Referral Disclosure Protocol and settling those matters with the agency.
  • Representing a provider in investigations by numerous Attorneys’ Generals involving alleged violations of state consumer protection laws.
  • Represented specialty laboratories in False Claims Act investigations in connection with the payment of processing and handling fees for specimen collection.
  • Represented a large physician practice in several investigations, including alleged violations of the Anti-Kickback Statute and False Claims Act violations stemming from medically unnecessary procedures and arrangements with referring physicians.
  • Conducted internal investigations of several health care providers and prepared self-disclosures to the U.S. Department of Health and Human Services, Office of Inspector General (OIG) and Centers for Medicare & Medicaid Services (CMS).
  • Represented several clinical laboratories and laboratory directors in administrative proceedings, opposing loss of CLIA certification and the imposition of the two-year owner/operator ban.
  • Successfully opposed the OIG’s proposed exclusion of a physician from participation in federal health care programs.
  • Settled numerous False Claims Act investigations without imposition of Corporate Integrity Agreements.
Read less

viewpoints

Already Enormous False Claims Act Penalties Set to Increase

May 6, 2016 | Blog | By Brian Dunphy, Samantha Kingsbury

The already enormous per-claim penalties under the federal False Claims Act (“FCA”) may nearly double by August 1, 2016, ratcheting up the stakes of FCA cases for health care providers, pharmaceutical and medical device manufacturers, and life sciences companies subject to the FCA.
Read more
Yesterday, Mintz’s Health Care Enforcement Defense Group published its most recent Health Care Qui Tam Update.  This Update covers 42 health care-related False Claims Act qui tam cases that have been unsealed since the last Health Care Qui Tam Update.
Read more

Judge Sides with AseraCare, Grants Summary Judgment in $200 Million FCA Case

April 1, 2016 | Blog | By Laurence Freedman, Samantha Kingsbury

Much like the rest of the health care world, we have been following the AseraCare case since May of last year when the Alabama federal district court granted AseraCare’s motion to bifurcate its False Claims Act (FCA) trial into Phase I that would address “falsity” and Phase II that would address “knowledge” and other FCA elements.
Read more
On Monday, Alden Bianchi, Practice Group Leader of Mintz’s Employee Benefits & Executive Compensation practice, posted a detailed analysis of the Supreme Court’s recent decision Gobeille v. Liberty Mutual Insurance Company on Mintz’s Employment Matters blog.
Read more

Laboratories - 2015 Year in Review [VIDEO]

December 29, 2015 | Blog | By Joanne Hawana, Karen Lovitch, Samantha Kingsbury

Over the past year, significant regulatory changes began to take shape that will have lasting effects on the laboratory industry for years to come.
Read more

Mintz Advisory Analyzes Health Care Qui Tam Litigation Trends

December 15, 2015 | Blog | By Samantha Kingsbury

Last week, my colleague Kevin McGinty published a fascinating advisory that provides a detailed analysis of data recently released by the Department of Justice (“DOJ”) in its annual report on False Claims Act (“FCA”) filings.
Read more
On Tuesday, ML Strategies (MLS) posted its weekly Health Care Update, which provides information from the previous week on a variety of important health-care-related topics.
Read more

Jury Sides with DOJ in First Phase of FCA Statistical Sampling Trial

October 21, 2015 | Blog | By Samantha Kingsbury

Last week, a jury in Alabama federal court sided with the Department of Justice (DOJ) and qui tam relators in the first part of a False Claims Act (FCA) case against AseraCare Inc., a provider of hospice and palliative care services, and found that claims submitted by AseraCare for 104 patients were objectively false.
Read more
On Monday, ML Strategies (MLS) posted its weekly Health Care Update, which provides information from the previous week on a variety of important health care-related topics like implementation of the Affordable Care Act, Congressional initiatives affecting the health care industry, and state and federal health regulatory developments.
Read more
Last week, the Office of Inspector General (OIG) for the Department of Health and Human Services published Advisory Opinion 15-10 (Opinion). The Opinion addressed a hospital system’s proposal to lease non-clinician employees and provide operational and management services to a related psychiatric hospital.
Read more
Read less

News & Press

News Thumbnail Mintz

Health Law Practice Chair Karen Lovitch and Of Counsel Samantha Kingsbury were quoted in a G2 Intelligence special report about the 2024 lab enforcement landscape.

News Thumbnail Mintz
Mintz Member and Chair of the firm’s Health Law and Health Care Enforcement Defense Practices Karen Lovitch, Member Laurence Freedman, Of Counsel Samantha Kingsbury, and Associates Grady Campion and Caitlin Hill co-authored the Global Overview and corresponding United States chapter of the seventh edition of Lexology’s Healthcare Enforcement & Litigation 2022. Together these pieces outlined federal enforcement priorities in 2020, including matters involving opioids, COVID-19-related fraud, Medicare, and more, and look ahead to how health care enforcement is expected to evolve in the coming year. 
News Thumbnail Mintz
Given the many substantive and strategic lessons to be learned from FCA investigations and litigations, bankruptcy counsel advising the various constituents impacted by an FCA case should be mindful of these potential lessons, as they may raise issues relevant to the bankruptcy estate, says Health Law attorney Samantha Kingsbury in this article.
Karen Lovitch, practice leader of the Mintz Health Law Practice, Eoin Beirne, a Member in the firm’s Litigation practice, along with Associates Samantha Kingsbury and Mackenzie Queenin authored the last in a four-part series of articles on health care enforcement trends in 2017.
Three attorneys from Mintz author the second installment of a four-part series recapping key government policies, regulations and enforcement actions from 2016 and discussing their potential impacts on 2017.
News Thumbnail Mintz
Mintz Member and Chair of the Health Law Practice Karen S. Lovitch, Member Thomas S. Crane, and Associate Samantha P. Kingsbury co-authored a book published by the American Bar Association examining the federal Anti-Kickback Statute, one of the best-known federal fraud and abuse statutes, which prohibits transactions intended to induce or reward referrals for items or services reimbursed by the federal health care programs. The criminal statute has wide-ranging effects on business relationships in the health care, pharmaceutical, and medical device sectors.
Read less

podcasts

Health Law Diagnosed – New Year's Gratitude

February 3, 2025 | Podcast | By Bridgette Keller, Alison H. Peters, Samantha Kingsbury, Theresa Carnegie, Joanne Hawana, Abdie Santiago, Stephnie John, Pamela Polevoy, Karen Lovitch, Jean D. Mancheno, Deborah Daccord, Rachel A. Alexander, Jane Haviland, David Gilboa, Kathryn Edgerton, Hassan Shaikh, Madison Castle, Laurence Freedman, Priyanka Amirneni, Samantha Hawkins, Tara E. Dwyer, Rachel Yount, Sophia Temis, Xavier Hardy

Host Of Counsel Bridgette Keller invites the Mintz Health Law team to reflect on what they’re grateful for as they prepare for the year ahead. Hear from a dynamic group of Members, Of Counsel, and Associates as they share their perspectives on what’s coming up over the horizon.

Read more

Mintz Health Law: What We Are Grateful For

January 11, 2023 | Podcast | By Bridgette Keller

Bridgette Keller speaks with the Mintz Health Law team about what they are grateful for as they look back on a year of client service, mentorship, and working together as a team.

Read more
Read less

Events & Speaking

Speaker
Faculty
May
12
2016

Anti-Kickback Fundamentals

ABA | Health Law

Webinar

Read less

Publications

Co-author, What Is...The Anti-Kickback Statute?, Second Edition, Published by the American Bar Association (2022)

Read less

Recognition & Awards

  • Included on the Massachusetts Super Lawyers Rising Star: Health Care list (2017-2019)

  • Phi Beta Kappa

Read less

Involvement

  • Member, American Health Lawyers Association
Read less